Back | Next |
home / stock / cytk / cytk message board
Subject | By | Source | When |
---|---|---|---|
Yes, now we are barcoding from one of those | LearningEveryTrade | investorshub | 10/07/2021 5:56:12 PM |
New high today Mkt likes their presentation Kiwi | Whalatane | investorshub | 10/07/2021 4:36:35 PM |
whytestocks: $CYTK News Article - Cytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil | whytestocks | investorshangout | 10/07/2021 2:35:53 PM |
That was a few days ago, the 28th. | LearningEveryTrade | investorshub | 10/01/2021 3:35:09 AM |
Cytokinetics: Cramer This is | Whalatane | investorshub | 09/30/2021 6:28:32 PM |
Inv Conference on Oct 7. | LearningEveryTrade | investorshub | 09/30/2021 3:10:39 PM |
Trying to be MOD. | LearningEveryTrade | investorshub | 09/30/2021 3:04:19 PM |
Volume iffy, I suppose. | LearningEveryTrade | investorshub | 09/30/2021 3:04:02 PM |
Great Price move.. | LearningEveryTrade | investorshub | 09/30/2021 3:03:42 PM |
Any News? | LearningEveryTrade | investorshub | 09/30/2021 3:03:18 PM |
At the time the pop looked overdone. | MiamiGent | investorshub | 09/13/2021 6:13:41 PM |
Whats the rational for being short ? | Whalatane | investorshub | 09/13/2021 5:20:28 PM |
$CYTK No worries. | MiamiGent | investorshub | 09/13/2021 2:29:46 AM |
Lets see how well that short position does | Whalatane | investorshub | 09/13/2021 1:34:04 AM |
whytestocks: $CYTK News Article - Shares of Cytokinetics Incorporated (CYTK) Rise Above Previous 52- | whytestocks | investorshangout | 08/27/2021 4:00:49 PM |
I am growing impatient waiting and there a | pzottkpz | investorshub | 08/16/2021 11:28:38 PM |
wow | pzottkpz | investorshub | 07/28/2021 7:19:21 PM |
stock holding up pretty nicely | pzottkpz | investorshub | 07/26/2021 9:54:11 PM |
$CYTK ...and dropped some more today | MiamiGent | investorshub | 07/26/2021 9:50:10 PM |
those pesky longs keep buying this stock | pzottkpz | investorshub | 07/24/2021 3:28:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Cytokinetics Incorporated Company Name:
CYTK Stock Symbol:
NASDAQ Market:
Primary Results and Two Additional Analyses from SEQUOIA-HCM to be Presented in a Late-Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress Opened Enrollment to CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population with Obstr...
SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that CEDAR-HCM ( C linical E valuation of D osing with A ficamten to R educe Obstruction in a Pediatric Population in HCM ), a clinical trial of ...
Data Support Advancement to Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 Full Data from the Phase 1 Study to be Presented at a Medical Congress in 2H 2024 SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWS...